{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:34:53Z","timestamp":1771652093758,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.amjoto.2021.103235","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T11:18:46Z","timestamp":1631704726000},"page":"103235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Xuewen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linbin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peichan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjoto.2021.103235_bb0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.amjoto.2021.103235_bb0010","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/cncr.25932","article-title":"Plasma epstein-barr virus DNA level strongly predicts survival in metastatic\/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy","volume":"117","author":"An","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.amjoto.2021.103235_bb0015","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/cncr.28001","article-title":"Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program","volume":"119","author":"Chan","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.amjoto.2021.103235_bb0020","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1200\/JCO.2006.07.7982","article-title":"Plasma epstein-barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma","volume":"24","author":"Leung","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjoto.2021.103235_bb0025","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3390\/cancers13081786","article-title":"Roles of inflammasomes in epstein-barr virus-associated nasopharyngeal cancer","volume":"13","author":"Looi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.amjoto.2021.103235_bb0030","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.amjoto.2021.103235_bb0035","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjoto.2021.103235_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","article-title":"Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial","volume":"13","author":"Chen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjoto.2021.103235_bb0045","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/annonc\/mdt163","article-title":"Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma","volume":"24","author":"Wu","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjoto.2021.103235_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2010.09.023","article-title":"A randomized trial on addition of concurrent-adjuvant chemotherapy and\/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma","volume":"98","author":"Lee","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.amjoto.2021.103235_bb0055","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjoto.2021.103235_bb0060","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","article-title":"Prevalence of prior cancer among persons newly diagnosed with cancer: an initial report from the surveillance, epidemiology, and end results program","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.amjoto.2021.103235_bb0065","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","article-title":"Anticipating the \u201csilver tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"25","author":"Bluethmann","year":"2016","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.amjoto.2021.103235_bb0070","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ijc.31543","article-title":"Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: a pan-cancer analysis of the SEER database","volume":"143","author":"Zhou","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.amjoto.2021.103235_bb0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar Behav Res"},{"key":"10.1016\/j.amjoto.2021.103235_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oraloncology.2019.01.023","article-title":"Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: implications for clinical trial accrual","volume":"90","author":"Wang","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.amjoto.2021.103235_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21037\/atm.2019.05.78","article-title":"Impact of prior cancer on outcomes in nasopharyngeal carcinoma","volume":"7","author":"Zhou","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.amjoto.2021.103235_bb0090","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.amjoto.2021.103235_bb0095","first-page":"7","article-title":"Jemal a cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.amjoto.2021.103235_bb0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/cer.15.27","article-title":"Should criteria for inclusion in cancer clinical trials be expanded?","volume":"4","author":"Gerber","year":"2015","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.amjoto.2021.103235_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju302","article-title":"Impact of prior cancer on eligibility for lung cancer clinical trials","volume":"106","author":"Gerber","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.amjoto.2021.103235_bb0110","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1002\/cam4.3301","article-title":"Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: a large-population retrospective analysis","volume":"9","author":"Qu","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.amjoto.2021.103235_bb0115","article-title":"Bone metastases pattern in newly diagnosed metastatic nasopharyngeal carcinoma: a real-world analysis in the SEER Database","author":"Yang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.amjoto.2021.103235_bb0120","doi-asserted-by":"crossref","first-page":"768","DOI":"10.21037\/atm.2019.11.75","article-title":"The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up","volume":"7","author":"Wu","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.amjoto.2021.103235_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4094395","article-title":"Patterns and prognostic value of lymph node metastasis on distant metastasis and survival in nasopharyngeal carcinoma: a surveillance, epidemiology, and end results study, 2006\u20132015","author":"Xu","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.amjoto.2021.103235_bb0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.amjoto.2021.103235_bb0135","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","article-title":"Management of nasopharyngeal carcinoma: current practice and future perspective","volume":"33","author":"Lee","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070921003367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070921003367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:09:06Z","timestamp":1759295346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070921003367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0196070921003367"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2021.103235","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2021.103235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103235"}}